Abstract:e11597 Background: On February 22, 2008, the Food and Drug Administration (FDA) granted accelerated approval for the use of bevacizumab (Avastin) in metastatic breast cancer. Based on the results of subsequent clinical trials this accelerated approval was revoked on November 18, 2011.In this study we categorize and analyze the newspaper reports related to bevacizumab use in advanced breast cancer. Methods: Using the FACTIVA media database, we reviewed all newspaper reports published in the United States and C… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.